Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 82

Similar articles for PubMed (Select 19061831)

1.

Ratcheting Myc.

Freie BW, Eisenman RN.

Cancer Cell. 2008 Dec 9;14(6):425-6. doi: 10.1016/j.ccr.2008.11.008.

2.

Translocations involving c-myc and c-myc function.

Boxer LM, Dang CV.

Oncogene. 2001 Sep 10;20(40):5595-610. Review.

3.

c-MYC: more than just a matter of life and death.

Pelengaris S, Khan M, Evan G.

Nat Rev Cancer. 2002 Oct;2(10):764-76. Review.

PMID:
12360279
4.

Pim1 promotes human prostate cancer cell tumorigenicity and c-MYC transcriptional activity.

Kim J, Roh M, Abdulkadir SA.

BMC Cancer. 2010 Jun 1;10:248. doi: 10.1186/1471-2407-10-248.

5.

The role of ornithine decarboxylase in c-Myc-induced apoptosis.

Packham G, Cleveland JL.

Curr Top Microbiol Immunol. 1995;194:283-90.

PMID:
7895500
6.
7.

Distinct thresholds govern Myc's biological output in vivo.

Murphy DJ, Junttila MR, Pouyet L, Karnezis A, Shchors K, Bui DA, Brown-Swigart L, Johnson L, Evan GI.

Cancer Cell. 2008 Dec 9;14(6):447-57. doi: 10.1016/j.ccr.2008.10.018.

9.

The proto-oncogene c-myc in hematopoietic development and leukemogenesis.

Hoffman B, Amanullah A, Shafarenko M, Liebermann DA.

Oncogene. 2002 May 13;21(21):3414-21. Review.

10.

The many faces of c-MYC.

Pelengaris S, Khan M.

Arch Biochem Biophys. 2003 Aug 15;416(2):129-36. Review.

PMID:
12893289
11.

The c-MYC oncoprotein as a treatment target in cancer and other disorders of cell growth.

Pelengaris S, Khan M.

Expert Opin Ther Targets. 2003 Oct;7(5):623-42. Review.

PMID:
14498825
12.

c-Myc is required for maintenance of glioma cancer stem cells.

Wang J, Wang H, Li Z, Wu Q, Lathia JD, McLendon RE, Hjelmeland AB, Rich JN.

PLoS One. 2008;3(11):e3769. doi: 10.1371/journal.pone.0003769. Epub 2008 Nov 20.

13.

Myc lacks E2F1's ability to suppress skin carcinogenesis.

Rounbehler RJ, Schneider-Broussard R, Conti CJ, Johnson DG.

Oncogene. 2001 Aug 30;20(38):5341-9.

14.

Functions of myc:max in the control of cell proliferation and tumorigenesis.

Hurlin PJ, Dezfouli S.

Int Rev Cytol. 2004;238:183-226. Review.

PMID:
15364199
15.

MYC in oncogenesis and as a target for cancer therapies.

Albihn A, Johnsen JI, Henriksson MA.

Adv Cancer Res. 2010;107:163-224. doi: 10.1016/S0065-230X(10)07006-5. Review.

PMID:
20399964
16.

Developmental context determines latency of MYC-induced tumorigenesis.

Beer S, Zetterberg A, Ihrie RA, McTaggart RA, Yang Q, Bradon N, Arvanitis C, Attardi LD, Feng S, Ruebner B, Cardiff RD, Felsher DW.

PLoS Biol. 2004 Nov;2(11):e332. Epub 2004 Sep 28.

17.

A DNA microarray screen for genes involved in c-MYC and N-MYC oncogenesis in human tumors.

Schuldiner O, Benvenisty N.

Oncogene. 2001 Aug 16;20(36):4984-94.

18.

Contrasting roles for c-Myc and L-Myc in the regulation of cellular growth and differentiation in vivo.

Morgenbesser SD, Schreiber-Agus N, Bidder M, Mahon KA, Overbeek PA, Horner J, DePinho RA.

EMBO J. 1995 Feb 15;14(4):743-56.

19.

The Myc oncoprotein as a therapeutic target for human cancer.

Vita M, Henriksson M.

Semin Cancer Biol. 2006 Aug;16(4):318-30. Epub 2006 Aug 3. Review.

PMID:
16934487
20.

Inhibition of cell differentiation: a critical mechanism for MYC-mediated carcinogenesis?

Leon J, Ferrandiz N, Acosta JC, Delgado MD.

Cell Cycle. 2009 Apr 15;8(8):1148-57. Epub 2009 Apr 10.

PMID:
19282668
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk